Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis

NCT02699905 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.

NCT NCT02699905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02699905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis
Lead sponsor
Milton S. Hershey Medical Center
Phase
Observational
Overall status
Withdrawn
Start date
August 31, 2016
Completion date
November 30, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal sepsis, multiple organ dysfunction, sepsis, septic shock